Victory Capital Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-238
| Closed | -$1.93K | – | 2633 |
|
2023
Q1 | $1.93K | Sell |
238
-3
| -1% | -$24 | ﹤0.01% | 2586 |
|
2022
Q4 | $2.85K | Hold |
241
| – | – | ﹤0.01% | 2577 |
|
2022
Q3 | $3K | Sell |
241
-50
| -17% | -$622 | ﹤0.01% | 2691 |
|
2022
Q2 | $10K | Sell |
291
-1
| -0.3% | -$34 | ﹤0.01% | 2654 |
|
2022
Q1 | $8K | Sell |
292
-8
| -3% | -$219 | ﹤0.01% | 2692 |
|
2021
Q4 | $13K | Sell |
300
-9
| -3% | -$390 | ﹤0.01% | 2720 |
|
2021
Q3 | $21K | Sell |
309
-16
| -5% | -$1.09K | ﹤0.01% | 2728 |
|
2021
Q2 | $25K | Buy |
325
+23
| +8% | +$1.77K | ﹤0.01% | 2694 |
|
2021
Q1 | $20K | Buy |
302
+87
| +40% | +$5.76K | ﹤0.01% | 2717 |
|
2020
Q4 | $7K | Buy |
215
+19
| +10% | +$619 | ﹤0.01% | 2524 |
|
2020
Q3 | $11K | Buy |
196
+28
| +17% | +$1.57K | ﹤0.01% | 2458 |
|
2020
Q2 | $6K | Sell |
168
-177
| -51% | -$6.32K | ﹤0.01% | 2486 |
|
2020
Q1 | $8K | Buy |
+345
| New | +$8K | ﹤0.01% | 3394 |
|
2019
Q4 | – | Sell |
-143
| Closed | -$7K | – | 3426 |
|
2019
Q3 | $7K | Buy |
+143
| New | +$7K | ﹤0.01% | 3376 |
|